HHMI
ICPT

Howard Hughes Medical Institute’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Howard Hughes Medical Institute’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-158
Closed -$37K – 199
2014
Q3 		$37K Sell
158
-9
-5% -$2.29K 0.01% 165
2014
Q2 		$40K Buy
+167
New +$44K 0.01% 149

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Howard Hughes Medical Institute's ICPT Position: Q4 2014 in Review

Howard Hughes Medical Institute sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2014, closing a stake of 158 shares — an estimated $37K sold.

Howard Hughes Medical Institute first reported a position in ICPT in Q2 2014 and held it in 2 quarters. The position peaked at $40K in Q2 2014. 169 funds tracked by Wall St. Rank hold ICPT as of Q4 2014.

  • Howard Hughes Medical Institute reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 158 Intercept Pharmaceuticals, Inc. shares in Q4 2014, an estimated $37K.
  • Howard Hughes Medical Institute first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • Howard Hughes Medical Institute's Intercept Pharmaceuticals, Inc. position peaked at $40K in Q2 2014.
  • 169 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2014.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2014, filed 11 Feb 2015.